MLH1 and carcinoma: Intrigued by the low rate of target gene mutations and absence of MLH1 hypermethylation in MSI-H rectal and sigmoid carcinomas in the test series, we validated these findings in an independent series of MSI-H carcinomas arising from several locations of the large bowel (Additional file 1, Table S1).